Overview Memantine and Antipsychotics Use Status: Terminated Trial end date: 2009-06-01 Target enrollment: Participant gender: Summary To investigate the potential to reduce concomitant antipsychotic medication use in subjects with moderate dementia of Alzheimer's type, treated with memantine. Phase: Phase 4 Details Lead Sponsor: Merz Pharmaceuticals GmbHTreatments: Antipsychotic AgentsMemantine